Acute coronary syndrome
RecruitingStudy on Reducing Antiplatelet Therapy in Patients with Acute Coronary Syndrome and High Bleeding Risk Using Prasugrel, Ticagrelor, or Clopidogrel
Study on Reducing Antiplatelet Therapy in Patients with Acute Coronary Syndrome and High Bleeding Risk Using Prasugrel, Ticagrelor, or Clopidogrel
- Disease:Acute coronary syndrome
- Substances:Acetylsalicylic AcidClopidogrel+2
Italy- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid
- Sponsor:Azienda Ospedaliera Universitaria Gaetano Martino Messina











